Quote of the day.
Journalists bought Pfizer's story today hook, line and sinker . . . background here.
But Healthcare Renewal brings some perspective:
"But isn't it odd that the investigators didn't compare the results of people who switched from Lipitor to simvastatin to people who switched from say, simvastatin to Lipitor, or from Lipitor to a third drug? One wonders whether their failure to consider alternative explanations of their data had something to do with the economic interests of their employer?It's also too bad that the media coverage of this study did not initially consider that there may be interpretations of its results other than those provided by its commercially sponsored study investigators."
Humble question: How come "simple bloggers" can put things in perspective and regular journalists can't?